SUBSCRIBE
SUBSCRIBE

Australia

Genetown
7 Mistakes That Annoy A Former HR Exec Who Reviewed Over 40K Resumes
August 29, 2017
 · 
1 min read
Genetown
From Benchtop To Boardroom: 4 Must-Have Transferable Skills For Scientists
August 29, 2017
 · 
1 min read
Genetown
The Worst Job In The World: Personal Assistant To 2 Biotech Professionals
August 29, 2017
 · 
1 min read
San Diego's Halozyme Lands Monster R&D Deals Worth $2 Billion+ From Bristol-Myers Squibb and Roche
Deals
CSL Behring Scoops Up This U.S. Biotech for $416 Million
August 28, 2017
 · 
3 min read
What Could Trump's Meltdown Mean for Biotech?
Biotech Beach
BioPharm Executive: What Could Trump’s Meltdown Mean for Biotech?
August 24, 2017
 · 
3 min read
Business
Despite Hurdles, GI Dynamics’s CEO is Still Excited About Endobarrier’s Future
August 23, 2017
 · 
1 min read
Biotech Bay
The Best And Worst Biotech IPOs Of 2017
August 23, 2017
 · 
1 min read
Genetown
How Job Seekers Negotiate For A Higher Salary
August 16, 2017
 · 
1 min read
Genetown
5 Careers A Chemistry Degree Could Take You
August 16, 2017
 · 
1 min read
Genetown
The Top Soft Skill Employers Want In Their Employees
August 16, 2017
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy
December 18, 2023
 · 
4 min read
BioMidwest
Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer
December 18, 2023
 · 
6 min read
Propanc Biopharma Engages Boutique Advisory Firm to Identify Strategic Investment Opportunities
December 18, 2023
 · 
4 min read
Recce Pharmaceuticals Reports Positive Preclinical Data of RECCE® 327 Against Gonorrhea
December 18, 2023
 · 
5 min read
Drug Development
Azura Ophthalmics Announces Positive Results from Phase 2 Clinical Trial of AZR-MD-001 in Patients with Contact Lens Discomfort
December 18, 2023
 · 
10 min read
Drug Development
Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
December 18, 2023
 · 
7 min read
Business
Propanc Biopharma’s Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP
December 13, 2023
 · 
4 min read
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
December 12, 2023
 · 
2 min read
First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix’s Breakthrough Kidney Cancer Imaging Agent
December 11, 2023
 · 
6 min read
Policy
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
December 7, 2023
 · 
3 min read
Immutep Receives A$2.6 million R&D Tax Incentive from French Government
December 7, 2023
 · 
1 min read
Drug Development
Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS
December 6, 2023
 · 
9 min read
Genetown
Bionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting
December 6, 2023
 · 
4 min read
Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01
December 6, 2023
 · 
3 min read
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
December 5, 2023
 · 
5 min read
Biotech Bay
Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
December 4, 2023
 · 
1 min read
Biotech Bay
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
December 4, 2023
 · 
7 min read
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
December 4, 2023
 · 
3 min read
Policy
Junshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGA
December 1, 2023
 · 
8 min read
Deals
Kazia Therapeutics Announces $2 Million Registered Direct Offering
December 1, 2023
 · 
5 min read
Load More